There are 383 resources available
185P - Clinicopathological characterization of NGS detected mutations in lung cancers: A single center experience
Presenter: Julia Walter
Session: Poster Display session
186P - CIP2A modulates PKM2 dimer-tetramer transition through phosphorylation of serine 287 in non-small cell lung cancer
Presenter: lijun Liang
Session: Poster Display session
187P - Development of a magnetic nanostructure for co-delivery of metformin and silibinin on growth of lung cancer cells: Possible action through leptin gene and its receptor regulation
Presenter: Davoud Jafari-Gharabaghlou
Session: Poster Display session
188P - Efficacy of SARS-CoV-2 based mRNA vaccines for patients with thoracic malignancies with 6 months follow up: A prospective observational study
Presenter: Urska Janzic
Session: Poster Display session
189P - Assessment of seroconversion after SARS-CoV2 vaccination in patients with lung cancer
Presenter: Ioannis Trontzas
Session: Poster Display session
190P - COVID-19 pandemic impact on lung cancer patient’s performance status and access to treatment: A comparative study pre and during COVID-19 era
Presenter: Rute Fernandes
Session: Poster Display session
191P - Lung cancer care in Europe during COVID-19: Findings from a global survey of patient experience
Presenter: Jackie Fenemore
Session: Poster Display session
85P - Adjuvant osimertinib in patients (pts) with stage IB-IIIA EGFR mutation positive (EGFRm) NSCLC after complete tumour resection: ADAURA China subgroup analysis
Presenter: wang jie
Session: Poster Display session
86P - Aumolertinib as adjuvant therapy in postoperative EGFR-Mutated non-small cell lung cancer
Presenter: Qingyi Zhang
Session: Poster Display session
87P - Patient reported physical function (PF) predicts long-term survival in early-stage NSCLC surgical patients
Presenter: Cecilia Pompili
Session: Poster Display session